Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

J&J Names Top Executive to Lead China Operations

publication date: Aug 29, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Johnson & Johnson has emphasized the importance of China by restructuring its China operations and putting a single high-powered executive in charge of all three of its China business segments (pharmaceuticals, medical devices/diagnostics and consumer healthcare). To show that it is serious about China, J&J selected Jesse Wu, who had been Global Head of Consumer Healthcare for the company, to oversee its China operations. Mr. Wu’s Consumer Healthcare division generated $14.4 billion of revenue for J&J last year, while China was responsible for a much smaller $2.5 billion of the company’s sales. Apparently, J&J wants to make sure its China operations are fully optimized. More details....

Stock Symbol: (NYSE: JNJ)

Share this with colleagues:  

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...